Ovid Therapeutics Inc. (OVID) scores 60 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 0.05, representing a 98% premium to fair value. Quantitative score: 50/100. Qualitative score: 100/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.